The Centers for Medicare and Medicaid Services (CMS) released an updated Workers’ Compensation Medicare Set-Aside (WCMSA) Reference Guide , Version 3.1., dated May 11, 2020 Read more...

Listed below are brief updates on several recent policy developments across the country. Read more...

The Centers for Medicare and Medicaid Services (CMS) wants their money back and is going after payers to get conditional payments reimbursed. CMS has been sending notices to payers demanding payment, but many of the notices are going unanswered. That creates a two-fold problem. Interest accrues on the balance, and if there’s no response, the U.S. Treasury could seize the assets of the payer (i.e., carrier or self-insured employer). Read more...

Listed below are brief updates on several recent policy developments across the country. Read more...

Epidiolex oral solution ‒ the only cannabidiol (CBD) prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat epilepsy ‒ is no longer considered a controlled substance under the federal Controlled Substances Act. Read more...

The Workers' Compensation Medicare Set-Aside Portal (WCMSAP) is updated monthly based on Average Wholesale Price (AWP) data from RED BOOK®.  Updates include a significant drop in the price of pregabalin (generic of Lyrica®), and a substantial decrease in the price of meloxicam (generic of Mobic®). Read more...

As you may have heard, meloxicam had a major price decrease within the last month. Meloxicam (generic formulation of Mobic) is a non-steroidal anti-inflammatory (NSAID), which is commonly prescribed for workers’ compensation injuries. Read more...

Montana requests insurers delay formulary implementation for legacy claims until COVID-19 crisis passes. And New York modifies formulary to extend implementation date for legacy scripts until January 1, 2021. Read more...